Search Results for: REEP6

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ADAT3 adenosine deaminase tRNA specific 3
  • tRNA modification in the nucleus and cytosol
Novel IZUMO4 IZUMO family member 4
  • Acrosome Reaction and Sperm:Oocyte Membrane Binding
Novel SCAMP4 secretory carrier membrane protein 4
Novel TMEM259 transmembrane protein 259
Novel ZNF554 zinc finger protein 554
  • Generic Transcription Pathway
AQP6 aquaporin 6
  • Passive transport by Aquaporins
ARL6IP1 ARL6 interacting reticulophagy regulator 1
ATP5PF ATP synthase peripheral stalk subunit F6
  • Formation of ATP by chemiosmotic coupling
  • Cristae formation
  • Mitochondrial protein degradation
BIK BCL2 interacting killer
CD79A CD79a molecule
  • CD22 mediated BCR regulation
  • Potential therapeutics for SARS
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Agammaglobulinemias, including the following six diseases: X-linked agammaglobulinemia (Bruton's agammaglobulinemia, XLA); IgM heavy chain gene deletions; Ig-alpha defect; Autosomal recessive agammaglobulinaemia; B cell-linker protein (BLNK) deficiency; Leucine-rich repeat-containing 8
CDC37 cell division cycle 37, HSP90 cochaperone
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Constitutive Signaling by EGFRvIII
  • Regulation of necroptotic cell death
  • Downregulation of ERBB2 signaling
  • RHOBTB2 GTPase cycle
  • Constitutive Signaling by Overexpressed ERBB2
  • Drug-mediated inhibition of ERBB2 signaling
  • Signaling by ERBB2 KD Mutants
  • Resistance of ERBB2 KD mutants to trastuzumab
  • Resistance of ERBB2 KD mutants to sapitinib
  • Resistance of ERBB2 KD mutants to tesevatinib
  • Resistance of ERBB2 KD mutants to neratinib
  • Resistance of ERBB2 KD mutants to osimertinib
  • Resistance of ERBB2 KD mutants to afatinib
  • Resistance of ERBB2 KD mutants to AEE788
  • Resistance of ERBB2 KD mutants to lapatinib
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Drug resistance in ERBB2 TMD/JMD mutants
CERT1 ceramide transporter 1
COQ8A coenzyme Q8A
  • Ubiquinol biosynthesis
  • Fostamatinib
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
  • Coenzyme Q10 deficiency
CYB561 cytochrome b561
CYB5R3 cytochrome b5 reductase 3
  • Vitamin C (ascorbate) metabolism
  • Phase I - Functionalization of compounds
  • Neutrophil degranulation
  • NADH
  • Flavin adenine dinucleotide
  • Copper
  • Methemoglobinemia
EBAG9 estrogen receptor binding site associated antigen 9
  • Estrogen-dependent gene expression
FHIP1B FHF complex subunit HOOK interacting protein 1B
GJA8 gap junction protein alpha 8
  • Gap junction assembly
GORASP2 golgi reassembly stacking protein 2
  • Golgi Cisternae Pericentriolar Stack Reorganization
GPR152 G protein-coupled receptor 152

Page 1 out of 3 pages